These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 537884)

  • 41. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 43. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sensitivity in vitro of 192 Proteus strains to several aminoglycosides].
    Thaller MC; Berchicchi R; Berlutti F; Maragoni F; Dainelli B
    Ann Sclavo; 1981; 23(1):57-63. PubMed ID: 7294918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
    Brummett RE; Fox KE; Bendrick TW; Himes DL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():73-83. PubMed ID: 659353
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Murray PR
    Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of in vitro activity of 3 aminoglycosides: sisomicin, tobramycin and gentamycin].
    Grima P
    G Ital Chemioter; 1978; 25(1):49-51. PubMed ID: 751849
    [No Abstract]   [Full Text] [Related]  

  • 50. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
    Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
    Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
    Rothenberger K; Friesen A; Streifinger W; Hofstetter A
    Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
    Vincent P; Vachée A; Izard D
    Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
    L'Hommedieu CS; Nicholas D; Armes DA; Jones P; Nelson T; Pickering LK
    J Pediatr; 1983 Apr; 102(4):629-31. PubMed ID: 6834204
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
    Sato K; Matsumiya H; Saito A
    Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The new aminoglycoside antibiotics.
    Fields BT
    J Ark Med Soc; 1976 Aug; 73(3):141-4. PubMed ID: 134018
    [No Abstract]   [Full Text] [Related]  

  • 60. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
    Forgan-Smith WR; McSweeney RJ
    Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.